GlaxoSmithKline (GSK) Reports Q2 EPS of 21.2p; Revs Slip
GlaxoSmithKline (NYSE: GSK) reported Q2 EPS of GBP0.21 ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
